Companies: 10,795·Total market cap: $144.5T
XORTX Therapeutics Inc.

XORTX Therapeutics Inc.

XRTXNASDAQHealthcare● Active
$2.23
+$0.05(+2.27%)
Market Cap$620863
P/E Ratio—
52W High$7.05
52W Low$1.725
Overview

XORTX Therapeutics Inc. (XRTX) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

XRTX · shares outstanding · updated Jun 9, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
189,385▲ +64.48% YoY Change
FY · as of Dec 31, 2025 · Reported in USD
vs 115,140 in FY 2024
Diluted Shares Outstanding
189,385
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+64.48%
year-over-year
Float (Free Float)
250,023
publicly tradable shares
89.8% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-09

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+47.4%
2022 → 2025
5-Year CAGRincreasing
+44.9%
2020 → 2025
10-Year CAGRincreasing
+37.1%
2015 → 2025
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2025Latest
Diluted Shares: 189,385
189,385
+64.48%
FY 2024
Diluted Shares: 115,140
115,140
+45.25%
FY 2023
Diluted Shares: 79,270
79,270
+33.91%
FY 2022
Diluted Shares: 59,195
59,195
+35.26%
FY 2021
Diluted Shares: 43,765
43,765
+47.75%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs XRTX
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+>999%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+>999%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+>999%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+>999%
#7
XORTX Therapeutics Inc.XRTX
XORTX Therapeutics Inc.YOU
189,385—

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

XORTX Therapeutics Inc. (XRTX) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2025, XORTX Therapeutics Inc. reports 189,385 basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

XORTX Therapeutics Inc.'s basic shares outstanding (189,385) represents currently issued shares. Diluted shares outstanding (189,385) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

XORTX Therapeutics Inc.'s float is 250,023 (89.8% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float250,023(89.8%)
Outstanding278,489

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

XORTX Therapeutics Inc. (XRTX) shares outstanding history from 2014 to 2025. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

XORTX Therapeutics Inc. shares outstanding for the fiscal year ending December 31, 2025 were 189,385, a 64.48% increase year-over-year. XORTX Therapeutics Inc. FY 2025 shares outstanding were 189,385, a +64.48% increase from FY 2024.

XORTX Therapeutics Inc. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +37.1% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

XRTX shares outstanding · 4 questions

As of December 31, 2025, XORTX Therapeutics Inc. (XRTX) has approximately 189,385 basic shares outstanding and 189,385 diluted shares outstanding. This represents a +64.48% year-over-year increase from FY 2024 (115,140). The increase may reflect equity compensation issuances or secondary offerings.

XRTX shares outstandinghow many shares does XRTX haveXRTX basic shares 2025XRTX diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · XORTX Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09